Cost-effectiveness of temozolomide for the threatment of newly diagnosed glioblastoma multiforme

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)235-241
Number of pages7
JournalExpert review of pharmacoeconomics & outcomes research
Volume9
Issue number3
DOIs
Publication statusPublished - 2009

Cite this